Real-world data in patients with hepatocellular carcinoma treated with transarterial chemoembolization: the second interim analysis of OPTIMIS

被引：1
|
作者：
Peck-Radosavljevic, M. [1 ,2 ]
Kudo, M. [3 ]
Lee, H. C. [4 ]
Cheng, A. -Lii [5 ]
Nakajima, K. [6 ]
Raoul, J. -L. [7 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Klinikum Klagenfurt Worthersee, Klagenfurt, Austria
[3] Kindai Univ, Fac Med, Osaka, Japan
[4] Asan Med Ctr, Seoul, South Korea
[5] Natl Taiwan Univ Hosp, Taipei, Taiwan
[6] Bayer HealthCare Pharmaceut, Whippany, NJ USA
[7] Inst Cancerol Ouest, Digest Oncol, Nantes, France
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
10.1016/S0168-8278(18)30614-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-164
引用
收藏
页码：S202 / S202
页数：1
相关论文
共 50 条
  • [31] Systemic chemotherapy improves outcome of hepatocellular carcinoma patients treated with transarterial chemoembolization
    Zhang, Wei-Chen
    Du, Ke-Yi
    Yu, Song-Feng
    Guo, Xue-E
    Yu, Han-Xi
    Wu, Dong-Yan
    Pan, Cheng
    Zhang, Cheng
    Wu, Jian
    Bian, Li-Fang
    Cao, Lin-Ping
    Yu, Jun
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2025, 24 (02) : 157 - 163
  • [32] Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
    Parikh, Neehar D.
    Zhang, Peng
    Singal, Amit G.
    Derstine, Brian A.
    Krishnamurthy, Venkat
    Barman, Pranab
    Waljee, Akbar K.
    Su, Grace L.
    CANCER RESEARCH AND TREATMENT, 2018, 50 (02): : 530 - 537
  • [33] Analytic Morphomics Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
    Parikh, Neehar D.
    Singal, Amit G.
    Zhang, Peng
    Krishnamurthy, Venkat
    Barman, Pranab
    Waljee, Akbar K.
    Su, Grace L.
    HEPATOLOGY, 2015, 62 : 420A - 421A
  • [34] Systemic chemotherapy improves outcome of hepatocellular carcinoma patients treated with transarterial chemoembolization
    WeiChen Zhang
    KeYi Du
    SongFeng Yu
    XueE Guo
    HanXi Yu
    DongYan Wu
    Cheng Pan
    Cheng Zhang
    Jian Wu
    LiFang Bian
    LinPing Cao
    Jun Yu
    Hepatobiliary & Pancreatic Diseases International, 2025, 24 (02) : 157 - 163
  • [35] A real-world study of Chinese hepatocellular carcinoma patients treated with TACE
    Hu, H-F
    Sang, Y-F
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (09) : 3091 - 3099
  • [36] TRANSARTERIAL CHEMOEMBOLIZATION VERSUS TRANSARTERIAL RADIOEMBOLIZATION FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA: A META-ANALYSIS
    Brown, Andrew
    Kassab, Ihab A.
    Chen, Vincent L.
    Townsend, Whitney A.
    Singal, Amit G.
    Parikh, Neehar D.
    HEPATOLOGY, 2019, 70 : 234A - 235A
  • [37] Sequential or simultaneous transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: A retrospective real-world study
    Liu, Jianwei
    Sun, Minmin
    Hu, Zhiliang
    Wang, Jie
    Lu, Caixia
    Gao, Ya
    He, Cuijuan
    Wu, Yeye
    Zhai, Jian
    Xia, Yong
    Pan, Xiaorong
    Wang, Kui
    PORTAL HYPERTENSION & CIRRHOSIS, 2024, 3 (02): : 105 - 115
  • [38] Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization
    Yossi Ventura
    Brian I Carr
    Issac Kori
    Vito Guerra
    Oren Shibolet
    World Journal of Gastroenterology, 2018, (15) : 1641 - 1649
  • [39] Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization
    Ventura, Yossi
    Carr, Brian I.
    Kori, Issac
    Guerra, Vito
    Shibolet, Oren
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (15) : 1641 - 1649
  • [40] Efficacy and safety of camrelizumab plus transarterial chemoembolization in intermediate to advanced hepatocellular carcinoma patients: A prospective, multi-center, real-world study
    You, Ran
    Xu, Qingyu
    Wang, Qi
    Zhang, Qingqiao
    Zhou, Weizhong
    Cao, Chi
    Huang, Xiangzhong
    Ji, Honghai
    Lv, Penghua
    Jiang, Hao
    Lu, You
    Jin, Yong
    Li, Yongjun
    Cheng, Long
    Wang, Weidong
    Xu, Hao
    Zhu, Xiaoli
    Yin, Guowen
    FRONTIERS IN ONCOLOGY, 2022, 12
12345